Walgreens Tops Estimates as Prescriptions Make Up for Retail

  • U.S. same-store retail segment sales decline 0.6 percent
  • Earnings are $1.03 a share, top analysts' estimate by 7 cents

Walgreens Boots Alliance Inc. beat analysts’ earnings estimates of fiscal first-quarter earnings estimates, as strong prescription drug trends made up for a retail slump that continues to affect the company.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.